1. Research Methodology and Executive Summary
1.1 Research Methodology
1.2 Executive Summary
2. Strategic Recommendations
3. Gene Therapy Market: Product Outlook
4. Global Gene Therapy Market: Sizing and Forecast
4.1 Market Size, By Value, Year 2015-2025
Table 1: Global Gene Therapy Market Size, By Value, 2015-2025 (USD Million)
Table 2: Global Prevalence of Neurological Disorders, 2015-2019 (In Billions)
Table 3: Global Prevalence of Cardiovascular Diseases, 2015-2019 (In Millions)
Table 4: Global Prevalence of Total Cancer, 2015-2019 (In Millions)
Table 5: Global Prevalence of Schizophrenia, 2015-2019 (In Millions)
Table 6: Global Prevalence of Alzheimer's Disease and Other Dementias, 2015-2019 (In Millions)
Table 7: Global Prevalence of Sickle Cell Disorders, 2015-2019 (In Millions)
Table 8: Global Prevalence of Mesothelioma, 2015-2019 (In Thousands)
5. Global Gene Therapy Market Segmentation By Vector Type, and By Application
5.1 Competitive Scenario of Global Gene Therapy Market: By Vector Type
Table 9: Global Gene Therapy Market, By Vector Type, 2019, 2025
5.1.1 Lentivirus Market Size and Forecast (2015-2025)
Table 10: Global Gene Therapy Market - By Lentivirus, By Value (USD Million), 2015-2025
5.1.2 AAV Market Size and Forecast (2015-2025)
Table 11: Global Gene Therapy Market - By AAV, By Value (USD Million), 2015-2025
5.1.3 Retrovirus & Gammaretrovirus Market Size and Forecast (2015-2025)
Table 12: Global Gene Therapy Market - By Retrovirus and Gammaretrovirus, By Value (USD Million), 2015-2025
5.1.4 Others Market Size and Forecast (2015-2025)
Table 13: Global Gene Therapy Market By Others, By Value (USD Million), 2015-2025
5.2 Competitive Scenario of Global Gene Therapy Market : By Application
Table 14: Global Gene Therapy Market, By Application, 2019, 2025
5.2.1 Neurological Disorders Market Size and Forecast (2015-2025)
Table 15: Global Gene Therapy Market - By Neurological Disorders, By Value (USD Million), 2015-2025
5.2.2 Cancer Market Size and Forecast (2015-2025)
Table 16: Global Gene Therapy Market - By Cancer, By Value (USD Million), 2015-2025
5.2.3 Cardiovascular Diseases Market Size and Forecast (2015-2025)
Table 17: Global Gene Therapy Market - By Cardiovascular Disorders, By Value (USD Million), 2015-2025
5.2.4 Others Market Size and Forecast (2015-2025)
Table 18: Global Gene Therapy Market - By Others, By Value (USD Million), 2015-2025
6. Global Gene Therapy Market: Regional Analysis
6.1 Competitive Scenario of Global Gene Therapy Market : By Region
Table 19: Global Gene Therapy Market, By Region, 2019, 2025
7. North America Gene Therapy Market: An Analysis (2015-2025)
7.1 North America Gene Therapy Market: Size and Forecast (2015-2025), By Value
Table 20: North America Gene Therapy Market Size, By Value, 2015-2025 (USD Million)
Table 21: North America Prevalence of Neurological Disorders, 2015-2019 (In Billions)
Table 22: North America Prevalence of Cardiovascular Diseases, 2015-2019 (In Millions)
Table 23: North America Prevalence of Total Cancer, 2015-2019 (In Millions)
Table 24: North America Prevalence of Schizophrenia, 2015-2019 (In Millions)
Table 25: North America Prevalence of Alzheimer's Disease and Other Dementias, 2015-2019 (In Millions)
Table 26: North America Prevalence of Sickle Cell Disorders, 2015-2019 (In Millions)
Table 27: North America Prevalence of Mesothelioma, 2015-2019 (In Thousands)
7.2 North America Gene Therapy Market Prominent Companies
7.3 Market Segmentation By Vector Type (Lentivirus, AAV, Retrovirus & Gammaretrovirus and Others)
Table 28: North America Gene Therapy Market - By Vector Type, By Value, 2015-2025 (USD Million)
7.4 Market Segmentation By Application (Neurological Disorders, Cancer, Cardiovascular Diseases and Others)
Table 29: North America Gene Therapy Market - By Application, By Value, 2015-2025 (USD Million)
7.5 North America Gene Therapy Market: Country Analysis
7.6 Market Opportunity Chart of North America Gene Therapy Market - By Country, By Value, 2025
Table 30: Market Opportunity Chart of North America Gene Therapy Market - By Country, By Value, 2025
7.7 Competitive Scenario of North America Gene Therapy Market : By Country
Table 31: North America Gene Therapy Market, By Country, 2019, 2025
7.8 United States Gene Therapy Market: Size and Forecast (2015-2025), By Value
Table 32: United States Gene Therapy Market Size, By Value, 2015-2025 (USD Million)
Table 33: United States Prevalence of Neurological Disorders, 2015-2019 (In Billions)
Table 34: United States Prevalence of Cardiovascular Diseases, 2015-2019 (In Millions)
Table 35: United States Prevalence of Total Cancer, 2015-2019 (In Millions)
Table 36: United States Prevalence of Schizophrenia, 2015-2019 (In Millions)
Table 37: United States Prevalence of Alzheimer's Disease and Other Dementias, 2015-2019 (In Millions)
Table 38: United States Prevalence of Sickle Cell Disorders, 2015-2019 (In Millions)
Table 39: United States Prevalence of Mesothelioma, 2015-2019 (In Thousands)
Table 40: United States Average Income and Expenditures of All Consumer Units, 2017, 2018 (In %)
7.9 United States Gene Therapy Market Segmentation - By Vector Type, and By Application (2015-2025)
Table 41: United States Gene Therapy Market - By Vector Type, By Value, 2015-2025 (USD Million)
Table 42: United States Gene Therapy Market - By Application, By Value, 2015-2025 (USD Million)
7.10 Canada Gene Therapy Market: Size and Forecast (2015-2025), By Value
Table 43: Canada Gene Therapy Market Size, By Value, 2015-2025 (USD Million)
Table 44: Canada Prevalence of Neurological Disorders, 2015-2019 (In Billions)
Table 45: Canada Prevalence of Cardiovascular Diseases, 2015-2019 (In Millions)
Table 46: Canada Prevalence of Total Cancer, 2015-2019 (In Millions)
Table 47: Canada Prevalence of Schizophrenia, 2015-2019 (In Millions)
Table 48: Canada Prevalence of Alzheimer's Disease and Other Dementias, 2015-2019 (In Millions)
Table 49: Canada Prevalence of Sickle Cell Disorders, 2015-2019 (In Millions)
Table 50: Canada Prevalence of Mesothelioma, 2015-2019 (In Thousands)
Table 51: Canada Average Income and Expenditures of All Consumer Units, 2017, 2018 (In %)
7.11 Canada Gene Therapy Market Segmentation - By Vector Type, and By Application (2015-2025)
Table 52: Canada Gene Therapy Market - By Vector Type, By Value, 2015-2025 (USD Million)
Table 53: Canada Gene Therapy Market - By Application, By Value, 2015-2025 (USD Million)
8. Europe Gene Therapy Market: An Analysis (2015-2025)
8.1 Europe Gene Therapy Market: Size and Forecast (2015-2025), By Value
Table 54: Europe Gene Therapy Market Size, By Value, 2015-2025 (USD Million)
Table 55: Europe Prevalence of Neurological Disorders, 2015-2019 (In Billions)
Table 56: Europe Prevalence of Cardiovascular Diseases, 2015-2019 (In Millions)
Table 57: Europe Prevalence of Total Cancer, 2015-2019 (In Millions)
Table 58: Europe Prevalence of Schizophrenia, 2015-2019 (In Millions)
Table 59: Europe Prevalence of Alzheimer's Disease and Other Dementias, 2015-2019 (In Millions)
Table 60: Europe Prevalence of Sickle Cell Disorders, 2015-2019 (In Millions)
Table 61: Europe Prevalence of Mesothelioma, 2015-2019 (In Thousands)
Table 62: European Union Household Expenditure, By Consumption Purpose, 2018 (In %)
8.2 Europe Gene Therapy Market Prominent Companies
8.3 Market Segmentation By Vector Type (Lentivirus, AAV, Retrovirus & Gammaretrovirus and Others)
Table 63: Europe Gene Therapy Market - By Vector Type, By Value, 2015-2025 (USD Million)
8.4 Market Segmentation By Application (Neurological Disorders, Cancer, Cardiovascular Diseases and Others)
Table 64: Europe Gene Therapy Market - By Application, By Value, 2015-2025 (USD Million)
8.5 Europe Gene Therapy Market: Country Analysis
8.6 Market Opportunity Chart of Europe Gene Therapy Market - By Country, By Value, 2025
Table 65: Market Opportunity Chart of Europe Gene Therapy Market - By Country, By Value, 2025
8.7 Competitive Scenario of Europe Gene Therapy Market : By Country
Table 66: Europe Gene Therapy Market, By Country, 2019, 2025
8.8 Germany Gene Therapy Market: Size and Forecast (2015-2025), By Value
Table 67: Germany Gene Therapy Market Size, By Value, 2015-2025 (USD Million)
Table 68: Germany Prevalence of Neurological Disorders, 2015-2019 (In Billions)
Table 69: Germany Prevalence of Cardiovascular Diseases, 2015-2019 (In Millions)
Table 70: Germany Prevalence of Total Cancer, 2015-2019 (In Millions)
Table 71: Germany Prevalence of Schizophrenia, 2015-2019 (In Millions)
Table 72: Germany Prevalence of Alzheimer's Disease and Other Dementias, 2015-2019 (In Millions)
Table 73: Germany Prevalence of Sickle Cell Disorders, 2015-2019 (In Millions)
Table 74: Germany Prevalence of Mesothelioma, 2015-2019 (In Thousands)
Table 75: Germany Household Expenditure, By Consumption Purpose, 2018 (In %)
8.9 Germany Gene Therapy Market Segmentation - By Vector Type, and By Application (2015-2025)
Table 76: Germany Gene Therapy Market - By Vector Type, By Value, 2015-2025 (USD Million)
Table 77: Germany Gene Therapy Market - By Application, By Value, 2015-2025 (USD Million)
8.10 France Gene Therapy Market: Size and Forecast (2015-2025), By Value
Table 78: France Gene Therapy Market Size, By Value, 2015-2025 (USD Million)
Table 79: France Prevalence of Neurological Disorders, 2015-2019 (In Billions)
Table 80: France Prevalence of Cardiovascular Diseases, 2015-2019 (In Millions)
Table 81: France Prevalence of Total Cancer, 2015-2019 (In Millions)
Table 82: France Prevalence of Schizophrenia, 2015-2019 (In Millions)
Table 83: France Prevalence of Alzheimer's Disease and Other Dementias, 2015-2019 (In Millions)
Table 84: France Prevalence of Sickle Cell Disorders, 2015-2019 (In Millions)
Table 85: France Prevalence of Mesothelioma, 2015-2019 (In Thousands)
Table 86: France Household Expenditure, By Consumption Purpose, 2018 (In %)
8.11 France Gene Therapy Market Segmentation - By Vector Type, and By Application (2015-2025)
Table 87: France Gene Therapy Market - By Vector Type, By Value, 2015-2025 (USD Million)
Table 88: France Gene Therapy Market - By Application, By Value, 2015-2025 (USD Million)
8.12 United Kingdom Gene Therapy Market: Size and Forecast (2015-2025), By Value
Table 89: United Kingdom Gene Therapy Market Size, By Value, 2015-2025 (USD Million)
Table 90: United Kingdom Prevalence of Neurological Disorders, 2015-2019 (In Billions)
Table 91: United Kingdom Prevalence of Cardiovascular Diseases, 2015-2019 (In Millions)
Table 92: United Kingdom Prevalence of Total Cancer, 2015-2019 (In Millions)
Table 93: United Kingdom Prevalence of Schizophrenia, 2015-2019 (In Millions)
Table 94: United Kingdom Prevalence of Alzheimer's Disease and Other Dementias, 2015-2019 (In Millions)
Table 95: United Kingdom Prevalence of Sickle Cell Disorders, 2015-2019 (In Millions)
Table 96: United Kingdom Prevalence of Mesothelioma, 2015-2019 (In Thousands)
Table 97: United Kingdom Household Expenditure, By Consumption Purpose, 2018 (In %)
8.13 United Kingdom Gene Therapy Market Segmentation - By Vector Type, and By Application (2015-2025)
Table 98: United Kingdom Gene Therapy Market - By Vector Type, By Value, 2015-2025 (USD Million)
Table 99: United Kingdom Gene Therapy Market - By Application, By Value, 2015-2025 (USD Million)
8.14 Italy Gene Therapy Market: Size and Forecast (2015-2025), By Value
Table 100: Italy Gene Therapy Market Size, By Value, 2015-2025 (USD Million)
Table 101: Italy Prevalence of Neurological Disorders, 2015-2019 (In Billions)
Table 102: Italy Prevalence of Cardiovascular Diseases, 2015-2019 (In Millions)
Table 103: Italy Prevalence of Total Cancer, 2015-2019 (In Millions)
Table 104: Italy Prevalence of Schizophrenia, 2015-2019 (In Millions)
Table 105: Italy Prevalence of Alzheimer's Disease and Other Dementias, 2015-2019 (In Millions)
Table 106: Italy Prevalence of Sickle Cell Disorders, 2015-2019 (In Millions)
Table 107: Italy Prevalence of Mesothelioma, 2015-2019 (In Thousands)
Table 108: Italy Household Expenditure, By Consumption Purpose, 2018 (In %)
8.15 Italy Gene Therapy Market Segmentation - By Vector Type, and By Application (2015-2025)
Table 109: Italy Gene Therapy Market - By Vector Type, By Value, 2015-2025 (USD Million)
Table 110: Italy Gene Therapy Market - By Application, By Value, 2015-2025 (USD Million)
9. Asia Pacific Gene Therapy Market: An Analysis (2015-2025)
9.1 Asia Pacific Gene Therapy Market: Size and Forecast (2015-2025), By Value
Table 111: Asia Pacific Gene Therapy Market Size, By Value, 2015-2025 (USD Million)
Table 112: Asia Pacific Prevalence of Neurological Disorders, 2015-2019 (In Billions)
Table 113: Asia Pacific Prevalence of Cardiovascular Diseases, 2015-2019 (In Millions)
Table 114: Asia Pacific Prevalence of Total Cancer, 2015-2019 (In Millions)
Table 115: Asia Pacific Prevalence of Schizophrenia, 2015-2019 (In Millions)
Table 116: Asia Pacific Prevalence of Alzheimer's Disease and Other Dementias, 2015-2019 (In Millions)
Table 117: Asia Pacific Prevalence of Sickle Cell Disorders, 2015-2019 (In Millions)
Table 118: Asia Pacific Prevalence of Mesothelioma, 2015-2019 (In Thousands)
9.2 Asia Pacific Gene Therapy Market Prominent Companies
9.3 Market Segmentation By Vector Type (Lentivirus, AAV, Retrovirus & Gammaretrovirus and Others)
Table 119: Asia Pacific Gene Therapy Market - By Vector Type, By Value, 2015-2025 (USD Million)
9.4 Market Segmentation By Application (Neurological Disorders, Cancer, Cardiovascular Diseases and Others)
Table 120: Asia Pacific Gene Therapy Market - By Application, By Value, 2015-2025 (USD Million)
9.5 Asia Pacific Gene Therapy Market: Country Analysis
9.6 Market Opportunity Chart of Asia Pacific Gene Therapy Market - By Country, By Value, 2025
Table 121: Market Opportunity Chart of Asia Pacific Gene Therapy Market - By Country, By Value, 2025
9.7 Competitive Scenario of Asia Pacific Gene Therapy Market : By Country
Table 122: Asia Pacific Gene Therapy Market, By Country, 2019, 2025
9.8 China Gene Therapy Market: Size and Forecast (2015-2025), By Value
Table 123: China Gene Therapy Market Size, By Value, 2015-2025 (USD Million)
Table 124: China Prevalence of Neurological Disorders, 2015-2019 (In Billions)
Table 125: China Prevalence of Cardiovascular Diseases, 2015-2019 (In Millions)
Table 126: China Prevalence of Total Cancer, 2015-2019 (In Millions)
Table 127: China Prevalence of Schizophrenia, 2015-2019 (In Millions)
Table 128: China Prevalence of Alzheimer's Disease and Other Dementias, 2015-2019 (In Millions)
Table 129: China Prevalence of Sickle Cell Disorders, 2015-2019 (In Millions)
Table 130: China Prevalence of Mesothelioma, 2015-2019 (In Thousands)
9.9 China Gene Therapy Market Segmentation - By Vector Type, and By Application (2015-2025)
Table 131: China Gene Therapy Market - By Vector Type, By Value, 2015-2025 (USD Million)
Table 132: China Gene Therapy Market - By Application, By Value, 2015-2025 (USD Million)
9.10 Japan Gene Therapy Market: Size and Forecast (2015-2025), By Value
Table 133: Japan Gene Therapy Market Size, By Value, 2015-2025 (USD Million)
Table 134: Japan Prevalence of Neurological Disorders, 2015-2019 (In Billions)
Table 135: Japan Prevalence of Cardiovascular Diseases, 2015-2019 (In Millions)
Table 136: Japan Prevalence of Total Cancer, 2015-2019 (In Millions)
Table 137: Japan Prevalence of Schizophrenia, 2015-2019 (In Millions)
Table 138: Japan Prevalence of Alzheimer's Disease and Other Dementias, 2015-2019 (In Millions)
Table 139: Japan Prevalence of Sickle Cell Disorders, 2015-2019 (In Millions)
Table 140: Japan Prevalence of Mesothelioma, 2015-2019 (In Thousands)
9.11 Japan Gene Therapy Market Segmentation - By Vector Type, and By Application (2015-2025)
Table 141: Japan Gene Therapy Market - By Vector Type, By Value, 2015-2025 (USD Million)
Table 142: Japan Gene Therapy Market - By Application, By Value, 2015-2025 (USD Million)
9.12 India Gene Therapy Market: Size and Forecast (2015-2025), By Value
Table 143: India Gene Therapy Market Size, By Value, 2015-2025 (USD Million)
Table 144: India Prevalence of Neurological Disorders, 2015-2019 (In Billions)
Table 145: India Prevalence of Cardiovascular Diseases, 2015-2019 (In Millions)
Table 146: India Prevalence of Total Cancer, 2015-2019 (In Millions)
Table 147: India Prevalence of Schizophrenia, 2015-2019 (In Millions)
Table 148: India Prevalence of Alzheimer's Disease and Other Dementias, 2015-2019 (In Millions)
Table 149: India Prevalence of Sickle Cell Disorders, 2015-2019 (In Millions)
Table 150: India Prevalence of Mesothelioma, 2015-2019 (In Thousands)
9.13 India Gene Therapy Market Segmentation - By Vector Type, and By Application (2015-2025)
Table 151: India Gene Therapy Market - By Vector Type, By Value, 2015-2025 (USD Million)
Table 152: India Gene Therapy Market - By Application, By Value, 2015-2025 (USD Million)
9.14 South Korea Gene Therapy Market: Size and Forecast (2015-2025), By Value
Table 153: South Korea Gene Therapy Market Size, By Value, 2015-2025 (USD Million)
Table 154: South Korea Prevalence of Neurological Disorders, 2015-2019 (In Billions)
Table 155: South Korea Prevalence of Cardiovascular Diseases, 2015-2019 (In Millions)
Table 156: South Korea Prevalence of Total Cancer, 2015-2019 (In Millions)
Table 157: South Korea Prevalence of Schizophrenia, 2015-2019 (In Millions)
Table 158: South Korea Prevalence of Alzheimer's Disease and Other Dementias, 2015-2019 (In Millions)
Table 159: South Korea Prevalence of Sickle Cell Disorders, 2015-2019 (In Millions)
Table 160: South Korea Prevalence of Mesothelioma, 2015-2019 (In Thousands)
9.15 South Korea Gene Therapy Market Segmentation - By Vector Type, and By Application (2015-2025)
Table 161: South Korea Gene Therapy Market - By Vector Type, By Value, 2015-2025 (USD Million)
Table 162: South Korea Gene Therapy Market - By Application, By Value, 2015-2025 (USD Million)
10. Global Gene Therapy Market Dynamics
10.1 Drivers
10.2 Restraints
10.3 Trends
11. Market Attractiveness
11.1 Market Attractiveness Chart of Global Gene Therapy Market - By Vector Type, 2025
Table 163: Market Attractiveness of Global Gene Therapy Market - By Vector Type, 2025
11.2 Market Attractiveness Chart of Global Gene Therapy Market - By Application, 2025
Table 164: Market Attractiveness of Global Gene Therapy Market - By Application, 2025
11.3 Market Attractiveness Chart of Global Gene Therapy Market - By Region, 2025
Table 165: Market Attractiveness of Global Gene Therapy Market - By Region, 2025
12. Competitive Landscape
12.1 Major Technological Innovations, Mergers & Acquisitions and Role of Manufacturers During COVID19
12.2 Product Pipeline of Leading Gene Therapy Companies
12.3 Market Share Analysis
Table 166: Market Share of Leading Global Gene Therapy Companies, 2019 (In %)
13. Company Analysis (Business Description, Financial Analysis, Business Strategy)
13.1 Voyager Therapeutics
Table 167: Voyager Therapeutics Revenue, 2015-2019 (In USD Million)
13.2 Novartis AG
Table 168: Novartis AG Revenue, 2015-2019 (In USD Billion)
Table 169: Novartis AG Net Revenue, By Business Segment, 2018 (In %)
Table 170: Novartis AG Net Revenue, By Business Segment, 2019 (In %)
Table 171: Novartis AG Net Revenue, By Geographic Segment, 2018 (In %)
Table 172: Novartis AG Net Revenue, By Geographic Segment, 2019 (In %)
13.3 Spark Therapeutics Inc.
Table 173: Roche Group Revenue, 2016-2019 (In USD Billion)
Table 174: Roche Group Net Revenue, By Business Segment, 2018 (In %)
Table 175: Roche Group Net Revenue, By Business Segment, 2019 (In %)
Table 176: Roche Group Net Revenue, By Geographic Segment, 2018 (In %)
Table 177: Roche Group Net Revenue, By Geographic Segment, 2019 (In %)
13.4 MoldMed S.P.A.
13.5 Orchard Therapeutics PLC
Table 178: Orchard Therapeutics PLC Revenue, 2018-2019 (In USD Million)
13.6 Alnylam Pharmaceuticals Inc.
Table 179: Alnylam Pharmaceuticals Inc. Revenue, 2015-2019 (In USD Million)
Table 180: Alnylam Pharmaceuticals Inc. Net Revenue, By Geographic Region, 2018 (In %)
Table 181: Alnylam Pharmaceuticals Inc. Net Revenue, By Geographic Region, 2019 (In %)
13.7 AnGes Inc.
Table 182: AnGes Inc. Revenue, 2015-2019 (In USD Million)
Table 183: Akcea Therapeutics Revenue, 2015-2019 (In USD Million)
13.8 Akcea Therapeutics
13.9 BlueBird Bio Inc.
Table 184: BlueBird Bio Inc. Revenue, 2015-2019 (In USD Million)
13.10 Sarepta Therapeutics
Table 185: Sarepta Therapeutics Revenue, 2015-2019 (In USD Million)